Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform

International MDS Working Groups: a model of success to improve diagnosis and treatment in rare... editorial memo (2014) 7:194–195 DOI 10.1007/s12254-014-0167-3 International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform Michael Pfeilstöcker Received: 31 July 2014 / Accepted: 5 August 2014 / Published online: 22 August 2014 © Springer-Verlag Wien 2014 The year 2013 marked the 10th anniversary of the Myelo- the heterogeneity of a disease—which is very prominent dysplastic Syndromes (MDS) Platform of the Austrian in MDS—but this may also apply to more common dis- Society for Hematology and Oncology. Although there eases when molecular heterogeneity becomes unveiled. had already been previously scientific contributions to Therefore, projects addressing diagnostic and prognostic this field, in 2003, the founding members of the platform markers are reasonable topics for collaborative working concluded that combined efforts of all MDS researchers groups: the platform has led a consensus conference in Austria would promote the outcome and recognition leading to a widely cited paper on diagnostic criteria of this work and improve clinical management of MDS in MDS [5]; furthermore, it has been instrumental in patients. To celebrate this anniversary, an educational designing the new international standard in prognosti- meeting in November 2013 provided a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform

Loading next page...
 
/lp/springer-journals/international-mds-working-groups-a-model-of-success-to-improve-sADOW1n9ux
Publisher
Springer Journals
Copyright
Copyright © 2014 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-014-0167-3
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2014) 7:194–195 DOI 10.1007/s12254-014-0167-3 International MDS Working Groups: a model of success to improve diagnosis and treatment in rare diseases: 10-year jubilee of the Austrian MDS platform Michael Pfeilstöcker Received: 31 July 2014 / Accepted: 5 August 2014 / Published online: 22 August 2014 © Springer-Verlag Wien 2014 The year 2013 marked the 10th anniversary of the Myelo- the heterogeneity of a disease—which is very prominent dysplastic Syndromes (MDS) Platform of the Austrian in MDS—but this may also apply to more common dis- Society for Hematology and Oncology. Although there eases when molecular heterogeneity becomes unveiled. had already been previously scientific contributions to Therefore, projects addressing diagnostic and prognostic this field, in 2003, the founding members of the platform markers are reasonable topics for collaborative working concluded that combined efforts of all MDS researchers groups: the platform has led a consensus conference in Austria would promote the outcome and recognition leading to a widely cited paper on diagnostic criteria of this work and improve clinical management of MDS in MDS [5]; furthermore, it has been instrumental in patients. To celebrate this anniversary, an educational designing the new international standard in prognosti- meeting in November 2013 provided a

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: Aug 22, 2014

There are no references for this article.